Tuesday, December 13, 2016

City of Hope Patient Forum this Saturday and IVIG and immunoglobulins in CLL (chronic lymphocytic leukemia)


Dr. Ben Kennedy

On Saturday, December 17th, we’ll be at the 2nd Annual Post-ASH CLL Patient Forum at City of Hope Medical Center in Duarte, CA. If you can make it, we’d love to see you there. You can access the flyer below and pre-registration is requested. We look forward to seeing you there!

Flyer: 


Pre-registration: 


Today we are posting an audio interview (and accompanying transcript) with Dr. Ben Kennedy who I spoke with during the 2016 CLL Horizons meeting in Belgrade Serbia a few weeks ago. We talked about how CLL affects our immune systems in addition to being a blood cancer. 
You can access that interview here.  


The next issue of The CLL Tribune will be coming out the week after Christmas. We’re busy editing, and doing the layout and putting on all the finishing touches. We’ll also be sharing the poster from ASH that many of you contributed to in our Q1 2016 Reader Poll. Stay tuned!

Newly-Forming CLL-Specific Support Groups

We are organizing some CLL-specific support groups in a variety of cities. Some of you may have attended a CLL educational meeting in that area, or just be interested in joining a support group. Click on the City to sign up and tell us about your preferences as we work to get them started. We appreciate those who expressed interest and have already completed the survey.


In the meantime….
Stay strong.
We are all in this together.
Brian Koffman, MD

12/12/16

Labels: , , , , , ,

Friday, March 13, 2015

The Kindness of Strangers: Getting my IVIG to Control my CLL (chronic lymphocytic leukemia) induced ITP

" I have always depended on the kindness of strangers."

Blanche DuBois from A Streetcar Named Desire

As did Blanche,  I too have depended on the kindness of strangers.

For the last nine years, every few weeks I show up at the cancer infusion center to sit for hours to receive intravenous immune globulin or IVIG. Recently I have stretched the interval between IVs to 7 weeks. 

By mechanisms that are not fully understood, it blocks my stupid auto-immune antibodies from attacking my own platelets that in the past has lead to multiple hospitalizations and fearful encounters with my own mortality when my platelet counts crashed and I was at risk for major bleeds. Thankfully, that is all behind me now.

I  have gradually and cautiously been able to taper off all the other meds for my ITP (immune thrombocytopenia) and my platelets have not fallen. 

Perhaps my ibrutinib helps turn off my auto-immune triggers. As seen in this recent post there is good reason to be hopeful. There are case reports of ACP-196, another promising BTK inhibitor helping too.

Perhaps I no longer need the IVIG, but I am not brave enough to stop it to find out. ITP is scary.

There is another reason not to quit.

My infusion 7 or 8 x year may also protect me from all sorts of infections. And that is important in my work as a doctor and in my fun as a grandfather where I exposed to lots of germs.

Due to the recent measles scare, all the doctors at the hospital where I work were ordered to have blood work to confirm their immunity. I objected for several reasons:
  1. I had had measles as a child
  2. Due to my CLL, I couldn't take the live vaccine even if my test came back negative.
  3. My antibody levels are not my own.
This last one is because of the IVIG that I receive. It is a pooled blood product from 1000s of strangers and by definition contains their antibodies against everything they have either had or been vaccinated against.

No wonder I was immune to everything that I was tested for.

But am I really?

Truth is that it's not me. It is the kindness of strangers' blood that is protecting me. It is known as "passive" immunity as I played no role in forming the antibodies. When the IVIG disappears as measured by the IGG level in my blood dropping after a few weeks as it must, my immunity fades too. IVIG does not boost IGA or IGM, two other important antibody classes, only IGG. 

Compare this to a vaccination where we attempt to mount an "active" immune response that is remembered and always ready to respond. Sadly in CLL, this is usually a barren effort. Flu shots and  other immunizations don't usually work well for us. And we must never risk getting a live vaccine as it might run amok in our bodies due to out immune-incompetence. We are notoriously lousy at making healthy antibodies.

So while I take my IVIG to protect my platelets, it is clearly helping me in other ways.

Thank you kind strangers. Your generous gift of your own blood has touched so many lives that you will never know.

Labels: , , , , , ,

Saturday, July 13, 2013

More Good Lab News

Our EHR (the electronic chart of all the medical records where I work and get my care) is down again, but before it crashed, I was able to view most of my lab results from 3 days ago.

Remember that I had gone a full six weeks between my lab tests and IVIG infusions to control by ITP, representing the longest period my veins haven't been probed for blood in the last seven years and the longest period ever between immunoglobulin infusions.

And the news was only good.

First the CBC.

For first time in many years, I have two blood counts in a row that showed no anemia. My hemoglobin was a robust 14.4.

My platelets were even better, an amazing 405,000. Although I have had a splenectomy, and they would be expected to be higher than in the reported average, this is still a super result, reinforcing the safety of the move to extend the time between infusions. It wasn't that long ago that I needed treatments every two weeks to keep my platelets in a safe range.

My absolute lymphocytes (ALC) was nice and low at 1.2. I want it low because those are the cells that make up my cancer. A high ALC usually means the leukemia has returned. My ANC (infection fighting neutrophils) was a healthy 6.2.

Blood chemistries showed that my liver and kidneys are doing a superior job of ridding me of any toxins or waste, and my sugar, minerals, and electrolytes are well balanced. Uric acid which often rockets up when taking cyclosporin as I do stayed well below the point when it comes out of solution and can cause the agonies of gout. This last result I particularly attribute to my vegan and nearly completely alcohol free diet.

Even my iron studies, consistently low in the past and likely one of the negative results of my longterm meatless diet, had inched their way into the bottom of the normal range, suggesting that using the cast iron skillet and eating more collard greens and molasses was slowly filling my empty tank.

And to top off the good times, my blood pressure was around 110/60 even with an IV in my arm.

When the computers are back up, I will check my Vitamin D, zinc and IGG levels.

I have grown accustomed to getting good lab results, but I never take them for granted and I am always grateful.

Next week, I am off to Ohio for my 84 day check in with yet another set of CT scans and more lab. On the way there, I am leaving early so that I can stop in the bay area to kvell (Yiddish for to feel proud and happy, especially applicable to one's offspring) over my granddaughters, and on the way home, I will be visiting friends in Missouri.

But that is the only travel planned for all of July! It is great to have some down time at home. Even with my boring labs, I still get tired and need my rest. Except for the fatigue, and the constant background noise about my impaired immunity and a host of other potential but G-d willing never going to happen concerns, my CLL is a non-event.

I believe that after this set of scans, I can go a whole six months between imaging, but not between visits to OSU and Dr. Byrd.  Enough scans already!

Starting late in August, American Airline will offer direct flights from LA to Columbus. It may be almost worth the unpredictable drive up the 405 from Newport Beach to LAX to avoid the stopover in Dallas or Chicago for my next trial visit. That could be nice.

I remain busy with prepping video and news material for the blog. Expect the second part of my ASCO 2013 Wierda interview on prognostic factors to be posted here soon.

Labels: , , , , , , , ,

Wednesday, July 10, 2013

ASCO 2013: Dr. Wierda Discusses Immune Therapies in CLL

In this first of several interviews from ASCO 2013, Dr. Bill Wierda of MDACC discusses immunity in general (or lack there of) in CLL and how that relates to the coming immune therapies.

He starts by explaining the basic difference between passive and active immune therapies.

His candid review of the trials so far points out the recurrent disappointments in the attempts to develop active immune therapies.

The story with passive immunity has had more success.

Monoclonal antibodies (mAb) such as rituximab or alemtuzumab were the pioneers of targeted immune therapy and have in many cases improved outcomes when added to chemotherapy without significantly increasing toxicity. Newer mAbs hold the promise of even deeper responses with few of the downsides of traditional chemotherapy and may even prove to work well without the addition of cytotoxic chemotherapy. Already useful examples include Rituximab and Revlimid or lenalidomide (R2) and the combo of HDMP (high dose methylprednisilone) + Ofatumumab. Powerful therapies with no chemo.

GA101 or obinutuzumab, a third generation anti CD20 mAB had received breakthrough status at the FDA and may be approved before the end of the year. The early data suggest this is both a potent and well tolerated treatment, hence the rush to get it to the clinic.

Passive immunity also includes the exciting CAR-T therapies that Dr. Wierda discusses. These are still in very early trials, but a few cases such as those out of U. Penn have seen spectacular saves when patients had all but ran out of all conventional options.

Immune modulating drugs (IMIDS) such as lenalidomide are in the early days of studies to figure out how they fit into the therapeutic landscape, but are clearly active in CLL and may improve some aspects of our impaired immunity,

This segues to another topic that gets Dr. Wierda really excited.

He tells of his research into ways to improve our immunity, to reconstitute our lost ability to fight off infections and to search and destroy the earliest microscopic cancers before they can grab hold and cause problems. Infections and secondary cancers are what kill those of us with CLL, and Dr. Wierda is fighting for ways not only to knock out our blood malignancy, but to also prevent us from dying not from our cancer itself, but from the damage the CLL (and its treatment) have already done to our ability to protect ourselves from infections and secondary malignancies.

This interview is from ASCO 2013 in June in Chicago.

It was great fun working with Andrew Schorr and the dedicated team from Patient Power in doing these interviews. I am grateful for their efforts and support and the willingness of the doctors to share their work at such a busy conference.

Look for more CLL interviews here over the next few weeks and keep checking Patient Power for other interviews that Andrew and I did on other cutting edge treatments for different cancers at ASCO in Chicago. Many of these have direct implications for how CLL may be treated in the future.

Here is Dr. Wierda:


Tomorrow it will be a full six weeks since my last IVIG infusion and blood draw. This is the longest I have gone without IVIG in the last six years and the longest I have gone without lab test since my first year with CLL.

I will report from the infusion center tomorrow.

Labels: , , , , , , , , , , , , , ,

Friday, June 14, 2013

IVIG: FDA Demands More Prominent Notification of the Risk of Blood Clots

I get IVIG for my ITP. It used to be every three weeks, but now I have been able to stretch it out to every six and my counts are still great. No one is really sure how it works for ITP, but there are theories that it coats my platelets and protects them from premature destruction. I also enjoy the added benefit of protection against infections.

But it comes with risks. I have discussed some before including infusion reactions and allergies, and renal disease. It is an expensive pooled blood product, so there is always the theoretical risk of an occult infection, but there is such extensive safety measures in place that I don't worry much about that one.

Now the FDA is highlighting the risk of blood clots (thrombosis) in a boxed warning.

Ironically those of us with ITP already have a simultaneously higher risk of both bleeding and clotting. How lucky can you be?

I don't plan to stop getting the infusions, though there is a good chance my ITP is no longer active, but why take the chance. Instead I will try to avoid hopping on a plane the day after an infusion as has been in the case many times in the past. Hydration, being active, and my omega 3 rich diet might also help mitigate risk. So would aspirin, but that's not for me with all my platelet problems in the past.

This is the communication directly from the FDA:


Vaccines, Blood & Biologics

FDA Safety Communication: New boxed warning for thrombosis related to human immune globulin products.


Date: June 10, 2013


Purpose: FDA has analyzed recent data that has strengthened the association between the use of intravenous, subcutaneous and intramuscular human immune globulin products and the risk of thrombosis. Additional caution regarding the use of these products is warranted.


Summary of Safety Issue 1 Recommendations for Patients 2 Recommendations for Health Professionals 3 Summary of Safety Issue


The U.S. Food and Drug Administration (FDA) is requiring manufacturers to add information on thrombosis to th current boxed warning in the labels of all intravenous human immune globulin products and to add a boxed warning to the labels of all subcutaneous and intramuscular human immune globulin products to highlight the risk of thrombosis and to add information on its mitigation.

A retrospective analysis of data from a large health claims-related database, as well as continued postmarketing adverse event reports of thrombosis have strengthened the evidence for an association between the use of intravenous, subcutaneous, and intramuscular human immune globulin products and the risk of thrombosis. This information necessitates a boxed warning for the entire class of products.
Human immune globulin products are used in a variety of conditions, both on and off-label, by healthcare professionals who may not be aware of the thrombosis risk and measures that could be taken to mitigate this risk.
Although all human immune globulin products already contain some information related to the risk of thrombosi in the current WARNINGS and PRECAUTIONS sections of their labels, FDA recognizes that the communication of this risk and its mitigation are not standardized. FDA proposes that for thrombosis a more prominent placement of risk information and a uniform approach for communicating the risk and its possible mitigation will help to reduce the occurrence of these serious adverse events.
The information on thrombosis in the boxed warning states:
Thrombosis may occur regardless of the route of administration.
Risk factors include: advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling central vascular catheters, hyperviscosity and cardiovascular risk factors.
Thrombosis may occur in the absence of known risk factors.
For patients at risk of thrombosis, administer at the minimum concentration available and at the minimum rate of infusion practicable.
Ensure adequate hydration in patients before administration.
Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk for hyperviscosity.

Recommendations for Patients


Patients should be aware of this risk and discuss this risk with their healthcare professionals.

Be aware that thrombosis is associated with human immune globulin products.
Talk to your healthcare professional about any risk factors or concerns you may have with human immune globulin products.
Contact your healthcare professional if you develop any signs or symptoms of thrombosis during or after receiving human immune globulin. Signs or symptoms of thrombosis may include:
pain and/or swelling of an arm or leg with warmth over the affected area
discoloration of an arm or leg
unexplained shortness of breath
chest pain or discomfort that worsens on deep breathing unexplained rapid pulse
chest pain
numbness or weakness on one side of the body


Recommendations for Healthcare Professionals


Healthcare professionals should be aware of the risk for thrombosis with human immune globulin products and ensure appropriate patient selection and monitoring.

Discuss with your patients the risk of thrombosis associated with these products.
Carefully consider risk factors when selecting patients for treatment with human immune globulin products

Monitor patients carefully for signs and symptoms of thrombosis both at the time of infusion and after infusion and encourage patients to report any signs or symptoms.
Report adverse events involving human immune globulin products to the FDA MedWatch program.

Labels: , , , ,

Friday, July 20, 2012

Giving my Veins a Rest. I've seen the Needle and the Damage Done

Ever since my low platelets appeared on the scene six years ago in my CLL battles, there has been very few weeks that I have not been poked or infused in one arm or the other often several times.

Except for the time of my transplant when I was having blood drawn four times a day and might have three or four infusions all hooked up at the same time, I have not a PICC (peripherally inserted central catheter) and I have never had a "port".

Here are my tips that I use for protecting my precious veins.

1: Showing up for any and all blood tests or cancer center appointments well hydrated and warm.
2: Regularly working my arms muscles with weights.
3: Applying pressure quickly and firmly for a few minutes when the the IV is withdrawn.
4: Following that with the compressive dressing COBAN for about another 30 minutes.
5: Most importantly asking for an experienced infusion nurse who gets no more than two tries before letting someone else have a go.

Over the last six years, I have received multiple therapies, at one time three infusions a week, and over the three months in Columbus for the Ibrutinib trial at OSU I got weekly ofatumumab infusions eight times. Add to that too many IVs for the contrast for my CT scans and too many blood draws, and it is a wonder my arms don't make look like those of a heroin addict.

This is another big advantage of the new small molecules- they can pass through the gut undamaged, so they are bioavailable orally. No more IVs. This isn't just more convenient. It is safer. It passes the control of our life saving meds and in some way of our cancer itself from the IV nurse and back to ourselves and our medicine cabinet at home.

My most constant companion over the last six years has not been rituximab or steroids, but the very precious IVIG for my ITP. When my platelet count dropped again the last time, Dr. Kipps recommended that I restart my IVIG but that this time I receive less each dose but get it more frequently, every two weeks, and I dutifully did just that for years. IVs every two weeks! I am now trying to stretch out that two week interval, not that I don't just love spending hours at the friendly infusion center more than twice a month. Not that I don't love having to plan every trip or vacation or appointment around the scheduling of my life saving protein elixir dripping into my veins. I am happy that it has worked so well and that I have access to such a precious and expensive product on a predictable basis. I am truly dependent on the kindness of strangers whose pooled blood product regularly coats my platelets and prevents their premature and dangerous destruction. It is true at so many levels that I am living in gratitude.

Today it was almost four weeks since any needles have pieced my skin, and my platelet counts remained stellar. My Hgb has climbed a bit (13.2), my white blood cells are prefect (8.2, diff pending), and my platelets are 363,000, a very safe and happy number.

And my veins are loving the time off.

Maybe it's a benefit of all the ofatumumab. Makes sense since rituximab helps ITP and they both target CD20+ cells. Maybe it is the ibrutinib reducing my disease burden, the driver of my distorted immune function, or maybe it is some direct effect the BTK blockage has on auto-immune function.

Once a month IVIG. Two more doses of ofatumumab.

A lifetime of cancer controlling pills?

This is a fine vision of my future.

Labels: , , ,

Tuesday, May 24, 2011

THE PLAN: More of the same

So here's the plan.

As of today. It could change tomorrow.

This is mostly a medical post, so those who aren't CLL or transplant aficionados might want to skim it quickly or skip to the last few paragraphs.

As you know from my spotty posting, my status has been delightfully boring with little new to report.

To understand what I am planning to do, it is important to see it for what it is: more of the same.

Let's go back to last spring when I started down this very smooth path.

Allow me to briefly summarize my journey over the last 12 months.

Almost two years post transplant, my platelets had fallen again, this time over four weeks from 242,000 to 32,000 in May 2010 despite low dose IVIG infusions (30 grams) twice a month.

With the platelet crash I was re-staged to be sure it was ITP.

It was.

My CT scan showed the largest cluster of nodes was way too big: 6.4 x 3.4 cm. on the right side of my mesentery. The flow cytometry showed CLL was back in my peripheral blood again. My ALC was normal but my atypical lymph count had reached 12%. Red cells were fine and I could feel some small palpable nodes in my neck, but nothing worrisome.

So besides the ITP, it was all too clear that the CLL was stealthily but forcefully on the move again.

Yucch.

That's when it was decided to go back to what had worked so well before my transplant, the unusual but magic mix of ciclosporin (CSP) 150 mg twice a day and some heavy cycles of rituximab (R) at 500/M2 weekly x 6. And continue the IVIG unchanged.

It worked quickly. My platelets jumped up immediately and were soon a non-issue again.

As of now, my ITP as measured by my platelet count seems to be stable or even trending upward with numbers often well above the amazing level of 400,000, and never below 270,000 for almost a year now. The therapy is working great for ITP!

After the first cycle of rituximab, my follow up CT scan in September 2010 showed my largest node was 3.8 x 1.7 cm, still much too big, but also much better. My ALC was low to low-normal ranging from 0.52 to 0.79, likely from the R wiping out all my B cells. My bone marrow showed about 5-10% CLL on the biopsy and 3% by flow cytometry.

Not just my ITP, but my CLL was responding to this non-chemo therapy as it had done before.

So I did a second round of 6 weekly doses of rituximab starting in October and finishing late in November. During this time, I also had to reduce the CSP because of its well known nasty side effects when my uric acid jumped to 9.4 (really should be less than 6 but we can accept as high as 8) and when my blood pressure shot up. Thankfully renal function (creatinine and eGFR) stayed in the normal range this time, unlike my last CSP scare.

I eventually readjusted my BP meds and halved the CSP to 75 mg twice a day, which is my present dose. Uric acid is fine again, creatinine has climbed a touch but is still normal, and my BP is great to high normal. It depends on who is checking it. It is always great at my office and alway borderline at the cancer center.

Not a perfect portrait, but not bad. I can't imagine what these renal parameters would be if I wasn't vegan. I do believe my anti-inflammatory diet moderates some of the toxicity of my disease and its treatments.

My ALC is now up to normal ranging from 0.7 to 1.2.

My Hgb has dipped as low as 12.7 but last week was a robust 15. It fluctuates between a bit low and low normal. My red cells are always slightly too big or macrocytic, but it is not progressive.

The few tiny nodes that never went away in my neck after the first round of R therapy didn't change much with the second hit of monoclonal antibody, but they were tiny.

The bone marrow biopsy on March 30 showed 3% CLL on flow, and < 5% on the biopsy. Even better than 6 months earlier. It also showed some mild hypocellularity (30%), which means it may have been beaten up more than I realize with the transplant. FISH studies for the usual suspects for MDS and CLL were negative. All in all a very good result.

The next important piece of the puzzle is the imaging.

Here there is a new wrinkle in the strategy. I am switching to MR. My hospital has just installed a new more powerful machine, and although the details won't be as precise as on a CT, it will be good enough for a new baseline. Truth is that I don't need to know if my nodes are 1.9 or 2.2 cm but I do need to know if they are 2 or 4 cm. All future imaging will be on this same machine, and hopefully this will eliminate the Morton's fork of too much radiation or not enough information. The scan will be in mid June.

What I do know is that my palpable nodes are definitely growing very slowly. Kipps agrees. Is it because of the reduction of the CSP as the nodes seemed to enlarge after the last drop in dosage, or is that the R finally wearing off (it has been 6 months since the last infusion), or is it just what it is.

Unless the MR finds the bad or good extreme of either massive nodes or no nodes, I will be doing 6 weeks of R again in late June through early August. 6-12 weeks later I will repeat the MR.

During this time I will continue on the same dose of CSP and then try to stretch out the IVIG to three weeks between treatments which will also spare my veins, which are getting a little inflamed from years of abuse by the IV nurses.

I hope to make only one change at a time so I can monitor the effect.

After that, I will try to reduce the CSP to 50 mg twice a day, but I am nervous about going lower than that. Rai is not keen on my stopping the ciclosporin, ever.

After that more R again in 6 months and another BMB and MR scan somewhere in there, depending on how things go this summer.

If this is smelling a lot like rituximab maintenance with the every six month dosing, it might be.

But I believe it is more than that because clearly the CSP has anti-leukemic properties proven in the test tube and a few published cases and at least twice in this little body of mine. It is a novel low toxicity combination therapy that probably should be better studied.

I believe this approach is using CSP and R to treat to goal, to shrink those mesenteric nodes.

Maybe I will need to add something like AMD3100 or CAL 101 to get the B cells out of the nodes, but I will cross that bridge if and when I need to.

Imagine no chemotherapy and getting a complete remission!

The plan:

More R, slowly reduce the CSP, and stretch out the IVIG, but don't totally stop either, and watch the nodes in the gut with a MR instead of a CT.

So I can avoid more chemo.

So I can feel well longer without damaging my marrow or likely making my cancer more aggressive or resistant and only mildly mangling my immunity.

So I can stay out of the 5th floor of City of Hope for a second transplant a little longer .

So I can wait out a possible cure without burning too many bridges.

So I can hug and hold my first grandchild, a girl due in July without dreading every cough or drool.

Labels: , , , , ,

Monday, October 5, 2009

All remains good in the land of platelets

My platelets were in the normal range -157,000- before the first drop of today's IVIG coursed through my veins. That is a drop from 220,000 on Set 18, but that was a full 17 days ago when I last got a dose of immunoglobulin. Today the count is not only still in the normal column on the report, it is way out of the danger zone of <30,000.

In fact, they haven't been out of the normal range since Aug 21, and their nadir was a very very safe 99,000.

The fall had actually started to level out before I started treatment. ITP has been known to hit hard and then peter out.

The CT scan in August had showed possible very small splenules. Sometimes after a splenectomy, small accessory spleens, dormant since birth, get a wake-up call and start growing to do the work of the missing spleen in gobbling up dead and dying red cells and platelets. Sometimes the splenectomy itself spills a few cells in the surgery itself that find a home in some warm vascular bed and start growing up. This is called splenosis. In either case, ITP or AIHA can return.

Neither these processes, by the way, have anything to do with the return of CLL. They can happen in garden variety ITP, with no cancer as the driver.

There are special scans (heat damaged RBC or the old school liver-spleen scan) to look for the suspect tissue, though there is some controversy on which is the best method. Either needs to matched up to the CT.

A glance under the microscope is much easier, cheaper, and radiation free. It may reveal Howell-Jolly bodies, that shouldn't be there if the spleen or splenules are doing the job. I have Howell-jolly bodies.

None of this is 100% predictive.

One option is to do the special scan, see if the suspect areas on the CT light up, and if they do, consider a second and much more minor outpatient laparoscopic accessory splenectomy.

The success rate is quite variable, between a 0-66% success rate. I suspect it depends on the experience of the surgeon along with other factors, such as age. I can find no literature saying that response to first splenectomy is predictive. Or if the presence of Howell-Jolly bodies have any prognostic significance. Size of the splenules is not a factor. Seems 0.5 cm mini-organs can do yeoman's work and when they are removed the chance of a cure is the same as those with bigger born again organs. Response to IVIG does predict good results with primary splenectomy. By the time I had my primary splenectomy 2 and 1/2 years ago, I was no longer responding to IVIG. The operation didn't work. But I sure am responding well now to the infusions every 2 weeks.

That said, while IVIG is a not remitting therapy, it is getting the job done with little muss and fuss and I kind of like the idea of maybe having a mini-spleen protecting me against encapsulated cocci with flu and pneumonia season on the way.

So unless Kanti Rai tells me otherwise, no more video games to be played in my belly for a while. If I have splenules, they can relax for a spell.

I am not sure if my platelet count would be safe even without the IVIG (remember the fall had maybe stopped in the week in August prior to starting treatment), but I am not going to stop it and try to find out. IVIG is after all IMMUNE globulin. It does double duty, protecting me against all things infectious, so I am not taking any chances and am instead counting my dual blessings.

I am doing well, and plan to continue to do so for a long long time.

Labels: , ,

Wednesday, July 15, 2009

Infusion Time Again

And I am no talking green tea infusions.

Tomorrow, I return to the Infusion Center  at the Cancer Clinic for the first time in over a year, the first time since I was discharged for my transplant last July. I am back for my old friend, the ultimate protein shake: Intravenous Immunoglobulin or IVIG as it is known to its fans and detractors.

It is a pooled blood product, screened and cleaned for all KNOWN infectious agents. The operative word is KNOWN. Could some unknown prion or virus be lurking, ready to strike in 20 years or the next time I might be neutropenic (low neutrophils or one type of white blood cells that fight infection)? Could be, but the track record over the last decades is perfect. No reason to expect trouble now. Plus I am planning on never being neutropenic again.

With my lowered immunity and the bugs in the air these days and the days to come, the risk of me dying from a pneumonia or the flu is pretty real and much more present. There is only the present, the Zen master teaches.

I will act on the known and not fear the unknown. IVIG here I come. No last minute cancellations this time around.

But being back in the "chair" at the Cancer Center is a stark reminder of my scary past when I alway wore long sleeves to hide the IV marks from my multiple treatments and lived in fear about what my next platelet count would show and even, at its darkest moments, if I would wake in the morning. It hints too at my uncertain future. 

And it confronts me with my present vulnerability.

But it is also a bond with the community of those still up to their eyebrows in their cancer fight. Not that I have left the fold. I pledge that I will never leave  the fold, even on the other side of a cure. That's where I am headed, and I plan to pull as many of you out of those troubled waters to the safety of that blessed shore. Maybe not pull you, but at least show you that it can be done and one way to do it. If IVIG is part of my swim to that promised land, so be it.

Labels: ,

Monday, June 8, 2009

JUST SAY NO TO IVIG

I decided  about 1 hour before I was due to start the infusion at 8 AM today to say no to IVIG.

All dressed up with nowhere to go.

Woke up upset and nauseous thinking about it.

It was to be used to prevent infections, but despite pneumonia times two before CLL, I've had no major illnesses since.

Admittedly I was on IVIG for about 18 months, but I have had the CLL diagnosis for 45 months. Most of the IVIG I received then was for my low platelets from ITP and it was a matter, not to put too fine a point on it, of life and death.

It is a very expensive pooled blood product, often obtained from paid donors. It is short supplies often.

The risks are potential. Some unknown infectious agent like an undiscovered unmeasured virus or prion is not found and not inactivated in the processing that causes a problem 10 or 20 years from now. It has yet to happen in years of use. And I have already had tons of it when I had ITP. 

The other concern is that it messes up my gentle raw vegan path to a cure with a mega dose of highly processed  IV protein. Now that is a totally wild conjecture, but it feels real. And you thought I was rational, calculating, and decisive. HA HA.

Its benefits are potential too.  Guidelines suggest you need to be getting serious bacterial infections to the tune of at least two a year, before you use this precious resource. Good hand washing and the occasional use of a N95 mask should do the job for me.

I have a friend, a fellow doctor with CLL, whose levels have been lower than mine for years with no issues, so it it not just wishful thinking to hold off.

My plan is to wait and rethink it- there is no urgencies. If my IGG level continues to tumble or more critically,  if I start getting bacterial infections, then I will need to revisit the decision.

But first I will go back to sleep.

Labels: ,

Tuesday, June 2, 2009

Low immunity

My immunoglobulins are very low.

That is not a surprise as they are the antibodies made by mature B cells, and I don't have many.

It is a well recognized, but poorly understood fact that even in remission, patients with CLL rarely see their immunoglobulins return to normal. The white count and red cells, the blood chemistries, even the tumor markers such as B2M may all return to normal. In a complete remission you could pass any insurance physical if you didn't have to answer any questions.

Until they checked your IGG, IGA, and IGM. They would invariably give away your cancer secret.

They just don't bounce back up. Mine sure haven't. Quite the opposite.

My IGM and IGA have been nearly the lower limits of the ability to be measured for a long long time, and they are still miserably low. That was expected.

The news is that my IGG sank below 400 to 369 for the first time since my diagnosis. Normal is between 700-1600. It fell 73 in less than two months.

What does this mean?

In terms of the CLL, probably not much. My B2M (an important prognostic factor that reflects tumor load) was a real low 1.4 and my CBC was great, so I don't think my cancer is active again. 

In terms of infection risk, it could mean a lot. You really need IGG to fight infections, especially bacterial invaders.

The good news is that there is an option: IVIG or intravenous immunoglobulin. It is a very expensive pooled blood product that is given over several hours in the infusion lab. Studies suggests it can reduce by half the risk of infections, especially life threatening pneumonia.

It means back to the cancer center, back in the IV chairs, back to all those awful premeds (steroids and anti-histamines).

So much for being Mister Natural.

It is a reminder of the cancer and will likely become a monthly routine.

But there is a good reason I am doing all this.

I need my immunity boosted because....

I am returning to work. Very very part time. Less that a full day a week. But it's a start.

It's been almost a full year since I last saw a patient in the office. It will be so good to get back to practicing medicine.

I am so happy and so excited.

Labels: